Mayne Pharma wins suit over Cosette’s termination of $672M takeover

M&A 2025-10-15 11:25 pm By Julia Kanapathippillai | Sydney

Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.